Cargando…
Peptides as Therapeutic Agents: Challenges and Opportunities in the Green Transition Era
Peptides are at the cutting edge of contemporary research for new potent, selective, and safe therapeutical agents. Their rise has reshaped the pharmaceutical landscape, providing solutions to challenges that traditional small molecules often cannot address. A wide variety of natural and modified pe...
Autores principales: | Rossino, Giacomo, Marchese, Emanuela, Galli, Giovanni, Verde, Francesca, Finizio, Matteo, Serra, Massimo, Linciano, Pasquale, Collina, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609221/ https://www.ncbi.nlm.nih.gov/pubmed/37894644 http://dx.doi.org/10.3390/molecules28207165 |
Ejemplares similares
-
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer
por: Tesei, Anna, et al.
Publicado: (2022) -
Urea-based anticancer agents. Exploring 100-years of research with an eye to the future
por: Listro, Roberta, et al.
Publicado: (2022) -
Sigma-1 Receptor Agonists Acting on Aquaporin-Mediated H(2)O(2) Permeability: New Tools for Counteracting Oxidative Stress
por: Pellavio, Giorgia, et al.
Publicado: (2021) -
Tackling Antimicrobial Resistance with Small Molecules
Targeting LsrK: Challenges and Opportunities
por: Linciano, Pasquale, et al.
Publicado: (2020) -
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)
por: Rossino, Giacomo, et al.
Publicado: (2020)